Hospital consumables could be next in line for NPPA price control as regulators examine steep markups and growing calls for structured price monitoring.
AI-backed cancer care gains international attention as India-built iOncology.ai earns recognition at BRICS while moving toward clinical validation.
USFDA inspections across three Indian-linked pharma facilities reveal varied compliance outcomes, from minimal observations to Form 483 and VAI classification.
MSD has inaugurated a technology centre in Hyderabad, strengthening its global technology network and supporting Human Health through digital and enterprise capabilities.
Alembic’s Vadodara facility completes a major compliance turnaround, moving from a warning letter to a zero-observation USFDA inspection.
The government panel backs continued home drug delivery, prioritizing medicine access for vulnerable patients while calling for tighter online sales enforcement.
Ayurveda seeks to bridge tradition and modern medicine through preventive healthcare, evidence-based research, innovation, and integrative care.
India’s peptide API race heats up as HRV Pharma commits Rs 150 crore to expand synthetic peptide and high-potency oncology API capacity.
Roche Pharma India announced the winners of the third edition of the Leading Engagements to Advance Patient Care (LEAP) program.
Chronic care and GLP-1 therapeutics are reshaping the Indian Pharmaceutical Market as long-term therapies drive growth, demand, and investment.
.jpg)
, CDSCO.jpg)
